REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 183 filers reported holding REPLIGEN CORP in Q3 2016. The put-call ratio across all filers is 2.58 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $212,755 | -75.1% | 1,338 | -77.8% | 0.01% | -73.9% |
Q2 2023 | $853,004 | +282.4% | 6,030 | +355.1% | 0.02% | +283.3% |
Q1 2023 | $223,077 | -2.3% | 1,325 | -1.7% | 0.01% | -14.3% |
Q4 2022 | $228,230 | -13.2% | 1,348 | -3.9% | 0.01% | -22.2% |
Q3 2022 | $263,000 | +17.4% | 1,402 | +1.8% | 0.01% | +12.5% |
Q2 2022 | $224,000 | -65.6% | 1,377 | -60.2% | 0.01% | -57.9% |
Q1 2022 | $651,000 | -25.5% | 3,463 | +4.9% | 0.02% | -24.0% |
Q4 2021 | $874,000 | -7.9% | 3,301 | +0.5% | 0.02% | -16.7% |
Q3 2021 | $949,000 | +51.8% | 3,283 | +4.8% | 0.03% | +50.0% |
Q2 2021 | $625,000 | -9.4% | 3,133 | -11.7% | 0.02% | -23.1% |
Q1 2021 | $690,000 | +109.1% | 3,549 | +106.3% | 0.03% | +100.0% |
Q4 2020 | $330,000 | +21.3% | 1,720 | -6.8% | 0.01% | 0.0% |
Q3 2020 | $272,000 | +19.8% | 1,846 | +0.7% | 0.01% | +8.3% |
Q2 2020 | $227,000 | +16.4% | 1,833 | -9.3% | 0.01% | -7.7% |
Q1 2020 | $195,000 | +31.8% | 2,020 | +26.2% | 0.01% | +62.5% |
Q4 2019 | $148,000 | +7.2% | 1,600 | 0.0% | 0.01% | 0.0% |
Q3 2019 | $138,000 | 0.0% | 1,600 | 0.0% | 0.01% | 0.0% |
Q2 2019 | $138,000 | +31.4% | 1,600 | -9.7% | 0.01% | +14.3% |
Q1 2019 | $105,000 | +12.9% | 1,771 | 0.0% | 0.01% | -12.5% |
Q4 2018 | $93,000 | +4.5% | 1,771 | +10.7% | 0.01% | +33.3% |
Q3 2018 | $89,000 | +14.1% | 1,600 | 0.0% | 0.01% | 0.0% |
Q2 2018 | $78,000 | +25.8% | 1,600 | -7.2% | 0.01% | +20.0% |
Q1 2018 | $62,000 | +21.6% | 1,725 | +23.2% | 0.01% | +25.0% |
Q4 2017 | $51,000 | -5.6% | 1,400 | 0.0% | 0.00% | -33.3% |
Q3 2017 | $54,000 | -6.9% | 1,400 | 0.0% | 0.01% | -25.0% |
Q2 2017 | $58,000 | +18.4% | 1,400 | 0.0% | 0.01% | +14.3% |
Q1 2017 | $49,000 | +16.7% | 1,400 | 0.0% | 0.01% | -12.5% |
Q3 2016 | $42,000 | +10.5% | 1,400 | 0.0% | 0.01% | -11.1% |
Q2 2016 | $38,000 | 0.0% | 1,400 | 0.0% | 0.01% | -10.0% |
Q1 2016 | $38,000 | -5.0% | 1,400 | 0.0% | 0.01% | -23.1% |
Q4 2015 | $40,000 | +2.6% | 1,400 | 0.0% | 0.01% | +8.3% |
Q3 2015 | $39,000 | -32.8% | 1,400 | 0.0% | 0.01% | -29.4% |
Q2 2015 | $58,000 | +41.5% | 1,400 | 0.0% | 0.02% | +54.5% |
Q1 2015 | $41,000 | +13.9% | 1,400 | 0.0% | 0.01% | 0.0% |
Q4 2014 | $36,000 | +89.5% | 1,400 | 0.0% | 0.01% | +10.0% |
Q4 2013 | $19,000 | – | 1,400 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
12 West Capital Management LP | 1,021,641 | $295,244,000 | 13.47% |
Ally Bridge Group (NY) LLC | 70,000 | $20,229,000 | 5.95% |
Miura Global Management | 85,000 | $24,564,000 | 3.81% |
Conestoga Capital Advisors, LLC | 871,390 | $251,823,000 | 3.48% |
Ranger Investment Management | 187,723 | $54,250,000 | 2.90% |
AWM Investment Company, Inc. | 100,000 | $28,899,000 | 2.84% |
Brown Capital Management | 1,017,477 | $294,041,000 | 2.41% |
Stephens Investment Management Group LLC | 558,287 | $161,339,000 | 2.19% |
Yorktown Management & Research Co Inc | 10,050 | $2,904,000 | 2.18% |
SV Health Investors, LLC | 14,541 | $4,203,000 | 2.06% |